Summary
Background
Global HIV programs continue to experience challenges achieving the
high rates of HIV testing and treatment needed to optimize health and reduce
transmission. Botswana represents a useful “demonstration
case” in assessing the feasibility of achieving the new UNAIDS
targets for 2020: 90% of all persons living with HIV knowing their status,
90% of these individuals receiving sustained antiretroviral treatment (ART),
and 90% of those on ART having virologic suppression
(“90–90–90”).
Methods
A population-based random sample of individuals was recruited and
interviewed in 30 rural and peri-urban communities from October 2013 to
November 2015 in Botswana as part of a large, ongoing PEPFAR-funded
community-randomized trial designed to evaluate the impact of a combination
prevention package on HIV incidence. A random sample of approximately 20% of
households in each of these 30 communities was selected. Consenting
household residents aged 16–64 years who were Botswana citizens or
spouses of citizens responded to a questionnaire and had blood drawn for HIV
testing in absence of documentation of positive HIV status. HIV-1 RNA
testing was performed in all HIV-infected participants, regardless of
treatment status.
Findings
Eighty-one percent of enumerated eligible household members took part
in the survey (10% refused and 9% were absent). Among 12,610 participants
surveyed, 3,596 (29%) were HIV infected; 2,995 (83·3%) of these
individuals already knew their HIV status. Among those who knew their HIV
status, 2,617 (87·4%) were currently receiving ART (this represented
95% of those eligible for ART by current Botswana national guidelines, and
73% of all HIV-infected persons). We obtained an HIV-1 RNA result in
99·7% of HIV-infected participants. Of the 2,609 individuals
currently receiving ART with a viral load measurement, 2,517 (96·5%)
had HIV-1 RNA ≤400 copies/mL. Overall, 70·2% of HIV-infected
persons had virologic suppression, close to the UNAIDS target of 73%.
Results of three sensitivity analyses to account for possible uncertainty
due to non-participation and under-representation of urban areas, revealed
somewhat lower, but nevertheless remarkably high 90–90–90
coverage.
Interpretation
Botswana, a resource-constrained setting with high HIV prevalence,
appears to have achieved very high rates of HIV testing, treatment coverage,
and virologic suppression for those on ART in this population-based survey,
despite the Botswana ART initiation threshold of ≤350
cells/mm3. These findings provide evidence that the UNAIDS
90-90-90 targets, while ambitious, are achievable even in
resource-constrained settings with high HIV burden.
Funding
The United States President’s Emergency Plan for AIDS Relief
(PEPFAR) through the Centers for Disease Control and Prevention (CDC).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.